Subscribe to CCP's monthly newsletter
Receive the latest news and updates, tools, events and job postings in your inbox every month
“We are proud to be able to continue serving people around the world who want to be protected from what is still a global pandemic,” says the director of the Breakthrough ACTION project.
“What this research shows is that strategies for pandemic response should include interventions to address financial barriers to health care as well as other financial impacts,” says CCP’s Tuo-Yen Tseng.
For three weeks ending in October, vaccine caravans spread out across Mozambique with a mission: Giving adolescents ages 12 to 17 the opportunity to get their first dose of COVID-19 vaccine.
CCP researchers found that many COVID-19 prevention strategies were seen as “anti-social” in Côte d’Ivoire, leading to less adherence. This knowledge has helped reframe COVID-19 messaging in the African nation.
A COVID rumor tracking system in Guyana created MythBusters materials to successfully provide the public with valid information and promote preventive behaviors, a CCP study finds.
Research conducted under CCP’s Breakthrough ACTION project is beginning to understand and target demand-side barriers to improve acceptance and uptake of the COVID-19 vaccine.
Two CCP teams – from Bangladesh and Côte d’Ivoire – will present their COVID-related work at a global virtual meeting on generating demand for COVID-19 vaccines.
During a recent holiday, CCP’s Breakthrough ACTION project educated travelers in Côte d’Ivoire about the benefits of COVID-19 vaccines – and provided free vaccinations at bus terminals and festivals for those interested.
CCP will receive $9.5 million to continue its work promoting COVID-19 vaccine uptake and acceptance in Asia and Africa.
Douglas Storey is being honored with the 2021-22 Excellence in International Public Health Practice award from the Johns Hopkins Bloomberg School of Public Health for his work on the COVID-19 Behaviors Dashboard.
Sign up to our monthly newsletter